CCI Clears Strategic Healthcare Investment Deal
The Competition Commission of India approved a complex investment deal involving TPG's growth funds, Asia Healthcare Holdings, and the Asian Institute of Nephrology and Urology, alongside various entities. This deal enhances healthcare services with a focus on urology, nephrology, maternal, and child care across India.
- Country:
- India
The Competition Commission of India has approved a significant investment deal involving global firm TPG's growth funds, South India-based healthcare provider AINU, and other entities. This announcement marks a pivotal step in expanding healthcare services in India.
The approved combination includes Waverly Pte Ltd, TPG Growth V SF Markets Pte Ltd, and Asia Healthcare Holdings among others. These entities are focused on enhancing their healthcare services, emphasizing maternal, child, urology, and nephrology care.
Rhea is a noted specialty hospital chain in India, concentrated on women's and childcare as well as in vitro fertilization services. Meanwhile, AINU specializes in urology, nephrology, and kidney transplants, operating seven hospitals in key Indian cities, including Hyderabad and Chennai.
ALSO READ
-
ADB’s $1.3 Billion Mongolia Plan Backs Better Healthcare, Schools and Disaster Readiness
-
African Development Bank Steps Up Push to Deliver Roads, Airport and Services in CAR
-
ADB’s Five-Year Plan Backs Better Services and More Jobs Across Papua New Guinea
-
Philippines Could Unlock Billions Through Smarter Taxes and Public Spending
-
African Venture Capital Gets a Boost as Oxford Programme Builds Investor Connections
Google News